跳至主要内容
临床试验/NCT02858414
NCT02858414已完成不适用

Exploratory Study of Cellular Reservoirs in Blood From HIV Infected Patients: EURECA (ERANET to Unravel New Roads to Eradication and a Cure for AIDS) Study

Centre Hospitalier Universitaire de Besancon2 个研究点 分布在 1 个国家目标入组 41 人开始时间: 2015年4月2日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
41
试验地点
2
主要终点
Measure of the integrated viral reservoir size

研究概览

简要总结

This study evaluates the impact of highly active antiretroviral therapy on the size of the latent viral reservoirs in resting CD4+ T cells and monocytes in HIV positive patients. The activation state of the cells will be assessed, by measuring the activation of Akt, to determine its influence on the size of the viral reservoirs.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Basic Science
盲法
None

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • HIV infected patients under Highly Active Anti-Retroviral Therapy (HAART) or Naïve from treatment

排除标准

  • Age limits
  • Pregnancy
  • Legal restrictions to consent

研究组 & 干预措施

blood sample

Experimental

干预措施: additional blood sample (Other)

结局指标

主要结局

Measure of the integrated viral reservoir size

时间窗: day 1

Measure by Alu-PCR. Results are given in number of integrated proviral DNA copies per 1 million cells.

Measure of the proviral reservoir size

时间窗: day 1

Measure by Total Proviral HIV DNA detection kit. Results are given in number of total proviral DNA copies per 1 million cells.

次要结局

  • Measure of Akt activation(day 1)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

Exploratory Study of Cellular Reservoirs in Blood... | 临床试验